Alyeska Investment Group
REPL icon

Alyeska Investment Group’s Replimune Group REPL Stock Holding History

Alyeska Investment Group’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,460
Closed -$265K – 663
2024
Q2 		$265K Buy
+29,460
New +$205K ﹤0.01% 521

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group's REPL Position: Q3 2024 in Review

Alyeska Investment Group sold out of Replimune Group (REPL) in Q3 2024, closing a stake of 29,460 shares — an estimated $265K sold.

Alyeska Investment Group first reported a position in REPL in Q2 2024 and held it in 1 quarter. The position peaked at $265K in Q2 2024. 144 funds tracked by Wall St. Rank hold REPL as of Q3 2024.

  • Alyeska Investment Group reported no remaining Replimune Group position as of Q3 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 29,460 Replimune Group shares in Q3 2024, an estimated $265K.
  • Alyeska Investment Group first reported a position in Replimune Group in Q2 2024 and held it in 1 quarter.
  • Alyeska Investment Group's Replimune Group position peaked at $265K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held Replimune Group as of Q3 2024.

Based on Alyeska Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.